FDA Inspection 1016834 — Jerome Goldschmidt
The FDA completed an inspection of Jerome Goldschmidt on May 5, 2017 in Blacksburg, VA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- May 5, 2017
- Fiscal Year
- 2017
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Blacksburg, VA (United States)
Additional Details
Clinical Investigator (CI)